Literature DB >> 18471781

Expression of steroidogenic enzymes and sex-steroid receptors in human prostate.

Georges Pelletier1.   

Abstract

Identification of the cell types expressing the steroidogenic enzymes and sex steroid receptors in the human prostate has recently been performed using immunocytochemistry and in-situ hybridization. The enzymes 3beta-hydroxysteroid dehydrogenase (3beta-HSD), which converts dehydroepiandrosterone (DHEA) into androstenedione, and type 5 17beta-HSD, which catalyzes the reduction of androstenedione to testosterone, have been localized in basal cells of alveoli as well as in stromal cells and endothelial cells of blood vessels. On the other hand, type-2 5alpha-reductase, which converts testosterone into the most potent androgen dihydrotestosterone (DHT), has been mostly observed in the luminal cells in alveoli. Aromatase, which converts testosterone into estradiol, has also been found to be expressed in the luminal cells of the alveoli as well as in stromal cells. Androgen receptor (AR) has been localized in luminal cell nuclei of alveoli and a large number of stromal cells, while estrogen receptor beta has been detected in both basal and luminal cells in alveoli and also in stromal cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18471781     DOI: 10.1016/j.beem.2008.02.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  20 in total

1.  Protein kinase Cα and Src kinase support human prostate-distributed dihydrotestosterone-metabolizing UDP-glucuronosyltransferase 2B15 activity.

Authors:  Sunit K Chakraborty; Nikhil K Basu; Sirsendu Jana; Mousumi Basu; Amit Raychoudhuri; Ida S Owens
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

Review 2.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

Review 3.  Development of adrenal cortex zonation.

Authors:  Yewei Xing; Antonio M Lerario; William Rainey; Gary D Hammer
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

4.  11-Ketotestosterone Is the Dominant Circulating Bioactive Androgen During Normal and Premature Adrenarche.

Authors:  Juilee Rege; Adina F Turcu; Josephine Z Kasa-Vubu; Antonio M Lerario; Gabriela C Auchus; Richard J Auchus; Joshua M Smith; Perrin C White; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2018-12-01       Impact factor: 5.958

5.  Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors.

Authors:  Nicholas Mitsiades; Clifford C Sung; Nikolaus Schultz; Daniel C Danila; Bin He; Vijay Kumar Eedunuri; Martin Fleisher; Chris Sander; Charles L Sawyers; Howard I Scher
Journal:  Cancer Res       Date:  2012-09-12       Impact factor: 12.701

Review 6.  Estrogen and androgen signaling in the pathogenesis of BPH.

Authors:  Clement K M Ho; Fouad K Habib
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

Review 7.  Targeting 5α-reductase for prostate cancer prevention and treatment.

Authors:  Lucas P Nacusi; Donald J Tindall
Journal:  Nat Rev Urol       Date:  2011-05-31       Impact factor: 14.432

8.  Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study.

Authors:  Peng Zhang; Wan-Li Hu; Bei Cheng; Yang-Jun Zeng; Xing-Huan Wang; Tong-Zu Liu; Wei-Bing Zhang
Journal:  Int Urol Nephrol       Date:  2015-12-19       Impact factor: 2.370

Review 9.  Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment.

Authors:  Melanie J Grubisha; Donald B DeFranco
Journal:  Steroids       Date:  2013-02-01       Impact factor: 2.668

10.  Age-dependent Increases in Adrenal Cytochrome b5 and Serum 5-Androstenediol-3-sulfate.

Authors:  Juilee Rege; Shigehiro Karashima; Antonio M Lerario; Joshua M Smith; Richard J Auchus; Josephine Z Kasa-Vubu; Hironobu Sasano; Yasuhiro Nakamura; Perrin C White; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2016-09-13       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.